IBEX Wealth Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,445
Closed -$353K 160
2022
Q2
$353K Buy
+10,445
New +$366K 0.08% 121
2021
Q4
Sell
-100
Closed -$3K 350
2021
Q3
$3K Buy
+100
New +$3.2K ﹤0.01% 423

Other funds holding OGN

IBEX Wealth Advisors's OGN Position: Q3 2022 in Review

IBEX Wealth Advisors sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 10,445 shares — an estimated $353K sold.

IBEX Wealth Advisors first reported a position in OGN in Q3 2021 and held it in 2 quarters. The position peaked at $353K in Q2 2022. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • IBEX Wealth Advisors reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • IBEX Wealth Advisors sold 10,445 Organon & Co shares in Q3 2022, an estimated $353K.
  • IBEX Wealth Advisors first reported a position in Organon & Co in Q3 2021 and held it in 2 quarters.
  • IBEX Wealth Advisors's Organon & Co position peaked at $353K in Q2 2022.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on IBEX Wealth Advisors's 13F filing for Q3 2022, filed 31 Oct 2022.